Followers

December 10, 2023

USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant

A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations. The USFDA inspected the facility from May 1-12, 2023.


No comments:

Post a Comment